Arteris (AIP) Projected to Post Quarterly Earnings on Thursday

Arteris (NASDAQ:AIP) is expected to post its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect Arteris to post earnings of ($0.08) per share and revenue of $18.55 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 4:30 PM ET.

Arteris Stock Up 2.1%

Arteris stock opened at $15.24 on Tuesday. Arteris has a 52-week low of $5.46 and a 52-week high of $19.85. The company has a market cap of $665.68 million, a P/E ratio of -18.36 and a beta of 1.48. The business has a 50-day simple moving average of $16.33 and a two-hundred day simple moving average of $13.17.

Insider Transactions at Arteris

In related news, CEO K Charles Janac sold 70,000 shares of Arteris stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $17.71, for a total transaction of $1,239,700.00. Following the sale, the chief executive officer owned 9,469,071 shares of the company’s stock, valued at approximately $167,697,247.41. This trade represents a 0.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Laurent R. Moll sold 17,937 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $17.92, for a total value of $321,431.04. Following the completion of the transaction, the chief operating officer directly owned 257,222 shares in the company, valued at approximately $4,609,418.24. This represents a 6.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 589,072 shares of company stock valued at $10,005,603 over the last 90 days. Company insiders own 33.70% of the company’s stock.

Hedge Funds Weigh In On Arteris

Several institutional investors have recently bought and sold shares of AIP. Boothbay Fund Management LLC increased its holdings in shares of Arteris by 49.0% in the third quarter. Boothbay Fund Management LLC now owns 68,681 shares of the company’s stock worth $694,000 after purchasing an additional 22,599 shares during the last quarter. UBS Group AG grew its holdings in Arteris by 80.8% during the 3rd quarter. UBS Group AG now owns 92,716 shares of the company’s stock valued at $936,000 after buying an additional 41,445 shares in the last quarter. Russell Investments Group Ltd. increased its stake in Arteris by 3,922.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 104,613 shares of the company’s stock worth $1,057,000 after acquiring an additional 102,012 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Arteris by 11.8% during the 2nd quarter. Bank of America Corp DE now owns 57,093 shares of the company’s stock worth $544,000 after acquiring an additional 6,008 shares in the last quarter. Finally, Ameriprise Financial Inc. bought a new position in shares of Arteris during the 2nd quarter valued at approximately $742,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AIP has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a report on Wednesday, January 21st. TD Cowen reissued a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $20.00 target price on shares of Arteris in a report on Monday, December 15th. Finally, Jefferies Financial Group raised Arteris to a “hold” rating in a report on Tuesday, October 28th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $17.50.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.